//Iksuda Therapeutics – Forging stable relationships for antibody-drug conjugates.

Iksuda Therapeutics – Forging stable relationships for antibody-drug conjugates.

Iksuda Therapeutics are featured in this month’s Nature magazine, a Q&A with their Chief Science Officer, Bob Lutz – Forging stable relationships for antibody-drug conjugates. Click on the link for the full article https://www.nature.com/articles/d42473-019-00358-3

2019-12-04T11:28:31+00:00